Notalvision
A digital health company providing remote patient monitoring services for retinal diseases.
Last updated September 1, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
Notal Vision is a digital health company that extends eye disease management from the clinic to the home, using AI-enabled data analysis. It offers remote monitoring services and home-based diagnostic devices for retinal diseases.
History
Notal Vision has its roots in Tel Aviv, Israel. The company developed ForeseeHome, a daily at-home test for Age-related Macular Degeneration (AMD). A large randomized clinical trial (AREDS2 HOME Study) conducted by the US National Eye Institute followed 1,520 dry AMD patients and demonstrated the vision benefit of ForeseeHome. Notal Vision launched the product and gained US Medicare reimbursement in late 2015. Today, headquarters is located in Manassas, Virginia, with R&D in Tel Aviv, led by CEO Kester Nahen, PhD.
Products and positioning
ForeseeHome
SCANLY Home OCT
Sources5 sources
Cite this profile: Cite the canonical profile. /brand-wiki/notalvision · Editorial policy · How profiles are compiled